Insulin-like growth factor-I regulates GPER expression and function in cancer cells

Oncogene

Volumn 32, Issue 6, 2013, Pages 678-688

  De Marco, P ^a   Bartella, V ^a   Vivacqua, A ^a   Lappano, R ^a   Santolla, M F ^a   Morcavallo, A ^b   Pezzi, V ^a   Belfiore, A ^b   Maggiolini, M ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

cancer cells; ERa; GPER; IGF I; signal transduction

Indexed keywords

CYCLIN D1; ESTROGEN RECEPTOR ALPHA; G PROTEIN COUPLED RECEPTOR 30; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C FOS; PROTEIN KINASE C DELTA; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CANCER CELL; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL TYPE; CONTROLLED STUDY; CTGF GENE; FIBROBLAST; FLUORESCENCE ANALYSIS; GENE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSACTIVATION; UPREGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENDOMETRIAL NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84873743039     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.97     Document Type: Article

References (54)

1. Pike MC, Pearce CL, Wu AH. Prevention of cancers of the breast, endometrium and ovary. Oncogene 2004; 23: 6379-6391.
2. Bai Z, Gust R. Breast cancer, estrogen receptor and ligands. Arch Pharm (Weinheim) 2009; 342: 133-149.
3. Kumar V, Chambon P. The estrogen receptor binds to its responsive element as a ligand-induced homodimer. Cell 1988; 55: 145-156.
4. Tsai SY, Tsai MJ, O' Malley BW. Cooperative binding of steroid hormone receptors contributes to transcriptional synergism at target enhancer elements. Cell 1989; 57: 443-448.
5. Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005; 146: 624-632.
6. Sirianni R, Chimento A, Ruggiero G, De Luca A, Lappano R, Andò S et al. The novel estrogen receptor GPR30 mediates the proliferative effects induced by17ßestradiol on mouse spermatogonial GC-1 cell line. Endocrinology 2008; 149: 5043-5051.
7. Prossnitz ER, Maggiolini M. Mechanisms of estrogen signaling and gene expression via GPR30. Mol Cell Endocrinol 2009; 308: 32-38.
8. Maggiolini M, Picard D. The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol 2010; 204: 105-114.
9. Filardo EJ, Quinn JA, Bland KI, Frackelton Jr AR. Estrogen-induced activation of Erk-1and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via transactivation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 2000; 14: 1649-1660.
10. Filardo EJ, Quinn JA, Frackelton Jr AR, Bland KI. Estrogen action via the G protein coupled receptor, GPR30:stimulation of adenylyl cyclase and c-AMP mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 2002; 16: 70-84.
11. Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A et al. G proteincoupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17b-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 2007; 67: 1859-1866.
12. Pandey DP, Lappano R, Albanito L, Madeo A, Maggiolini M, Picard D. Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J 2009; 28: 523-532.
13. Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V et al. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17 beta-estradiol and phytoestrogens in breast cancer cells. J Biol Chem 2004; 279: 27008-27016.
14. Albanito L, Sisci D, Aquila S, Brunelli E, Vivacqua A, Madeo A et al. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells. Endocrinology 2008; 149: 3799-3808.
15. Vivacqua A, Lappano R, De Marco P, Sisci D, Aquila S, De Amicis F et al. G proteincoupled receptor 30 expression is up-regulated by EGF and TGF a in estrogen receptor alpha-positive cancer cells. Mol Endocrinol 2009; 23: 1815-1826.
16. Filardo EJ, Graeber CT, Quinn JA, Resnick MB, Giri D, De Lellis RA et al. Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinic pathologic determinants of tumor progression. Clin Cancer Res 2006; 12: 6359-6366.
17. Smith HO, Leslie KK, Singh M, Qualls CR, Revankar CM, Joste NE et al. GPR30: a novel indicator of poor survival for endometrial carcinoma. Am J Obstet Gynecol 2007; 196: 1-11.
18. Stewart CE, Rotwein P. Growth, differentiation, and survival multiple physiological functions for insulin-like growth factors. Physiol Rev 1996; 76: 1005-1026.
19. LeRoith D, Roberts Jr CT. The insulin-like growth factor system and cancer. Cancer Lett 2003; 195: 127-137.
20. Belfiore A, Frasca F. IGF and insulin receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia 2008; 13: 381-406.
21. Rosenzweig SA, Atreya HS. Defining the pathway to insulin-like growth factor system targeting in cancer. Biochem Pharmacol 2010; 80: 1115-1124.
22. Belfiore A. The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer. Curr Pharm Des 2007; 13: 671-686.
23. Lann D, LeRoith D. The role of endocrine insulin-like growth factor-I and insulin in breast cancer. J Mammary Gland Biol Neoplasia 2008; 13: 371-379.
24. Baron S, Escande A, Alberola G, Bystricky K, Balaguer P, Richard-Foy H. Estrogen receptor and the activating protein-1 complex cooperate during insulin-like growth factor-i-induced transcriptional activation of the pS2/TFF1gene. J Biol Chem 2007; 282: 11732-11741.
25. Cascio S, Bartella V, Garofalo C, Russo A, Giordano A, Surmacz E. Insulin-like growth factor1 differentially regulates estrogen receptor-dependent transcription at estrogen response element and AP-1 sites in breast cancer cells. J Biol Chem 2007; 282: 3498-3506.
26. Mawson A, Lai A, Carroll JS, Sergio CM, Mitchell CJ, Sarcevic B. Estrogen and insulin/IGF-1cooperatively stimulate cell cycle progression in MCF7 breast cancer cells through differential regulation of c-Myc and cyclin D1. Mol Cell Endocrinol 2005; 229: 161-173.
27. Fagan DH, Yee D. Cross talk between IGF1R and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia 2008; 13: 423-429.
28. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995; 270: 1491-1494.
29. Lappano R, Maggiolini M. G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov 2011; 10: 47-60.
30. Young SH, Rozengurt E. Crosstalk between insulin receptor and G protein coupled receptor signaling systems leads to Ca2+ oscillations in pancreatic cancer PANC-1 cells. Biochem Biophys Res Commun 2010; 401: 154-158.
31. Kisfalvi K, Eibl G, Sinnett-Smith J, Rozengurt E. Metformin disrupts cross talk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth. Cancer Res 2009; 69: 6539-6545.
32. Vivacqua A, Bonofiglio D, Albanito L, Madeo A, Rago V, Carpino A et al. 17b Estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein coupled-receptor GPR30. Mol Pharmacol 2006; 70: 1414-1423.
33. Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Ando S et al. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17b-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol Endocrinol 2006; 20: 631-646.
34. Hess J, Angel P, Schorpp-Kistner M. AP-1subunits: quarrel and harmony among siblings. J Cell Sci 2004; 117: 5965-5973.
35. Madeo A, Maggiolini M. Nuclear alternate estrogen receptor GPR30 mediates 17bestradiol-induced gene expression and migration in breast cancer-associated fibroblasts. Cancer Res 2010; 70: 6036-6046.
36. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432: 332-337.
37. Song RX, Zhang Z, Chen Y, Bao Y, Santen RJ. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogenactivated protein kinase in MCF-7 breast cancer cells. Endocrinology 2007; 148: 4091-4101.
38. Bradley LM, Gierthy JF, Pentecost BT. Role of insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line. J Steroid Biochem Mol Biol 2008; 109: 185-196.
39. Stewart AJ, Johnson MD, May FE, Westley BR. Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogenstimulated proliferation of human breast cancer cells. J Biol Chem 1990; 265: 21172-21178.
40. Mendoza RA, Enriquez MI, Mejia SM, Moody EE, Thordarson G. Interactions between IGF-I, estrogen receptor-a (ERa), and ERb in regulating growth/apoptosis of MCF-7 human breast cancer cells. J Endocrinol 2011; 208: 1-9.
41. Soos MA, Field CE, Siddle K. Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem J 1993; 290: 419-426.
42. Pandini G, Vigneri R, Costantino A, Frasca F, Ippolito A, Fujita-Yamaguchi Y et al. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Clin Cancer Res 1999; 5: 1935-1944.
43. Zhang G, Li X, Zhang L, Zhao L, Jiang J, Wang J et al. The expression and role of hybrid insulin/insulin-like growth factor receptor type 1 in endometrial carcinoma cells. Cancer Genet Cytogenet 2010; 200: 140-148.
44. Leask A, Abraham DJ. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 2006; 23: 4803-4810.
45. Holbourn KP, Acharya KR, Perbal B. The CCN family of proteins: structure-function relationships. Trends Biochem Sci 2008; 33: 461-473.
46. Cortez V, Mann M, Brann DW, Vadlamudi RK. Extranuclear signaling by estrogen: role in breast cancer progression and metastasis. Minerva Ginecol 2010; 62: 573-583.
47. Cowley SM, Hoare S, Mosselman S, Parker MG. Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem 1997; 272: 19858-19862.
48. Daub H, Wallasch C, Lankenau A, Herrlich A, Ullrich A. Signal characteristics of G protein-transactivated EGF receptor. EMBO J 1997; 16: 7032-7044.
49. Dalle S, Ricketts W, Imamura T, Vollenweider P, Olefsky JM. Insulin and Insulin-like growth factor I receptors utilize different G protein signaling components. J Biol Chem 2001; 276: 15688-15695.
50. Rozengurt E, Sinnett-Smith J, Kisfalvi K. Cross talk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer. Clin Cancer Res 2010; 16: 2505-2511.
51. Akekawatchai C, Holland JD, Kochetkova M, Wallace JC, McColl SR. Transactivation of CXCR4 by the insulin-like growth factor-1 receptor (IGF-1R) in human MDA-MB-231 breast cancer epithelial cells. J Biol Chem 2005; 280: 39701-39708.
52. Recchia AG, De Francesco EM, Vivacqua A, Sisci D, Panno ML, Andò S et al. The G protein-coupled receptor 30 is up-regulated by hypoxia inducible factor-1a (HIF-1a) in breast cancer cells and cardiomyocytes. J Biol Chem 2011; 286: 10773-10782.
53. Chaqour B, Yang R, Sha Q. Mechanical stretch modulates the promoter activity of the profibrotic factor CCN2 through increased actin polymerization and NF-kappa B activation. J Biol Chem 2006; 281: 20608-20622.
54. Gerdes MJ, Myakishev M, Frost NA, Rishi V, Moitra J, Acharya A et al. Activator protein-1 activity regulates epithelial tumor cell identity. Cancer Res 2006; 66: 7578-7588.